Risiko for myopati, inklusive rhabdomyolyse, kan også øges med atorvastatin, som også metaboliseres via CYP3A4.
The risk of myopathy including rhabdomyolysis may also be increased with atorvastatin, which is also metabolised by CYP3A4.